Hormone Replacement Therapy Market Demand Analysis and Projected Huge Growth by 2026
Increasing number of products in development phase is expected to boost growth of the hormone replacement therapy market. For instance, Somapacitan sponsored by Novo Nordisk A/S, a Denmark-based company, completed phase 3 clinical trials in 2017. This drug is used for the treatment of growth hormone deficiency in adults.
View full press release